Mounjaro cost without insurance (2026)

Mounjaro is tirzepatide approved for type 2 diabetes. Its cash pricing sits in an odd place: about half of list through the manufacturer's own channel, and still meaningfully more than the identical molecule sold as Zepbound.

If you're researching weight loss: Mounjaro is not approved for it. Zepbound is the same molecule with the weight-management approval — and at $299–$449 a month self-pay, it's also the cheaper route. Our Zepbound cost page has every channel.

What Mounjaro costs, by route

RoutePriceConditionsSource
LillyDirect self-pay $499/mo All dose strengths, flat. Not usable with active commercial insurance, Medicare, or Medicaid. reported source
Mounjaro Savings Card as low as $25/mo Commercial insurance + a type 2 diabetes prescription required; terms and caps apply. reported source
Retail list price ~$1,023/mo Before any program, coupon, or coverage. reported source

The same molecule, priced two ways

Mounjaro and Zepbound are both tirzepatide from the same manufacturer. The label differs, the approved indication differs, and so does the self-pay program — Mounjaro is a flat $499 a month, while Zepbound is dose-tiered and starts lower:

Zepbound doseLillyDirect self-payvs Mounjaro flat $499
2.5 mg $299 $200/mo cheaper
5 mg $399 $100/mo cheaper
7.5 mg $449 $50/mo cheaper
10 mg $449 $50/mo cheaper
12.5 mg $449 $50/mo cheaper
15 mg $449 $50/mo cheaper

Zepbound rows from our tracked dataset, verified 2026-09-04. Maintenance pricing there requires refilling within 45 days.

If you're prescribed Mounjaro for type 2 diabetes

Prices reported from published sources on the date shown, not yet checkout-verified by us; the manufacturer's own page is the final word. Pricing journalism, not medical advice — indication and suitability are decisions for you and a licensed clinician. Some links may earn commissions; ordering is by cost, never compensation — disclosure.

Prices here change monthly. Get one email when they do. Free price-drop alerts →